Humacyte, Inc. HUMAW
Set alert
0.00 USD 0.00 -78.05%
As of Aug 25, 3:59 PM ET
0.0009 Day range 0.0039
0.0009 52-week range 0.0039
- YTD
- -99.12%
- 1 year
- -99.12%
- Open
- 0.23
- Prev close
- 0.0041
- Mkt cap
- 1.08M
- Vol
- 258.66K
- Avg vol
- 0
- EPS
- -3.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0009
- High
- 0.0039
- Forward P/E
- 0.00
- Beta
- 1.47
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Financial health
Altman Z-Score
-8.97 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -3.7×
FY 2019 5y median -4.0× FY 2025
P/S 74.5×
FY 2019 5y median 74.5× FY 2025
P/B 48.9×
FY 2019 5y median 2.4× FY 2025
P/FCF -1.4×
FY 2019 5y median -3.6× FY 2025
EV/EBITDA -7.5×
FY 2019 5y median -4.3× FY 2025
EV/Sales 81.6×
FY 2019 5y median 75.2× FY 2025
FCF Yield -69.7%
FY 2019 5y median -28.1% FY 2025
Profitability
Gross Margin -736.5%
FY 2019 5y median -427.5% FY 2025
Operating Margin -5271.7%
FY 2019 5y median -5271.7% FY 2025
Net Margin -2003.6%
FY 2019 5y median -764.5% FY 2025
ROE -1313.4%
FY 2019 5y median -21.7% FY 2025
ROIC -107.0%
FY 2019 5y median -89.1% FY 2025
ROA -35.1%
FY 2019 5y median -35.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 6.1%
FY 2019 FY 2025
EPS (diluted) 79.4%
FY 2019 FY 2025
Free Cash Flow -6.3%
FY 2019 FY 2025
Financial Health
Current Ratio 3.7×
FY 2019 5y median 4.5× FY 2025
Quick Ratio 3.0×
FY 2019 5y median 4.5× FY 2025
Debt / Equity 20.9×
FY 2019 5y median 0.4× FY 2025
Net Debt / EBITDA -0.6×
FY 2019 5y median 0.2× FY 2025
Interest Coverage -9.5×
FY 2019 5y median -13.6× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31